Paroxysmal nocturnal hemoglobinuria: new concepts in pathophysiology and treatment
Orphan Drugs Research and Reviews2015pp. 75–75
Citations Over Time
Abstract
Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematological disorder characterized by hemolysis, cytopenias, bone marrow dysfunction, and thrombosis. Over the last 20 years, we have seen a dramatic unraveling of the pathophysiology of this rare and complex disorder. As a result, new therapies involving complement inhibition have been developed, changing our understanding of the disease and improving outcomes for affected patients. Keywords: paroxysmal nocturnal hemoglobinuria, pathophysiology, treatment
Related Papers
- → The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab(2009)41 cited
- Spontaneous Remission of Paroxysmal Nocturnal Hemoglobinuria During Eculizumab Treatment(2014)
- → Paroxysmal Nocturnal Hemoglobinuria: Report Of Suboptimal Response To The Use Of Eculizumab(2015)
- → Fatigue Improvement after Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: Apropos of a Case(2012)
- Eight years of experience with eculizumab in a case of paroxysmal nocturnal hemoglobinuria(2019)